3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Role of dalbavancin as combination therapy: evidence from the literature and clinical scenarios.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The off-label use of dalbavancin in patients with infections other than acute bacterial skin and skin structure infections (ABSSSI) represents an interesting therapeutic option. Its use as monotherapy or in combination with other antibiotics should be better defined.

          Related collections

          Author and article information

          Journal
          Expert Rev Anti Infect Ther
          Expert review of anti-infective therapy
          Informa UK Limited
          1744-8336
          1478-7210
          Jul 2022
          : 20
          : 7
          Affiliations
          [1 ] Department of Clinical and Experimental Medicine, Unit of Infectious Diseases, University of Catania, Catania, Italy.
          [2 ] Unit of Clinical Pharmacology, Fatebenefratelli Sacco University Hospital, Milan, Italy.
          [3 ] Emergency Surgery Unit, San Filippo Neri Hospital, Rome, Italy.
          [4 ] Department of Biology, University of Pisa, Pisa, Italy.
          [5 ] Infectious Diseases Unit, Department of Clinical and Experimental Medicine, Azienda Ospedaliera Universitaria Pisana, University of Pisa, Pisa, Italy.
          [6 ] Clinic of Infectious Disease and Tropical Medicine, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, Milan, Italy.
          [7 ] Department of Medicine, University of Udine, Udine, Italy.
          [8 ] Department of Public Health and Infectious Diseases, 'Sapienza' University of Rome, Italy.
          Article
          10.1080/14787210.2022.2060820
          35353020
          5eb7e660-fc29-4087-be70-f6b89a73be88
          History

          bone infections,combination regimens,intravascular infections,prosthetic joint infections,subacute endocarditis,Dalbavancin

          Comments

          Comment on this article